67 related articles for article (PubMed ID: 3716909)
1. [Neuropathic changes observed in skeletal muscle tissue after vincristine administration].
Carpio González M; Fuentes García S; Palma Carazo P
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1986; 14(1):8-12. PubMed ID: 3716909
[No Abstract] [Full Text] [Related]
2. Studies on the morphological changes of skeletal muscle induced by vincristine, vinblastine and colchicine.
Konishi S; Kishida S
Bull Osaka Med Sch; 1984 Jul; 30(1):19-40. PubMed ID: 6544604
[No Abstract] [Full Text] [Related]
3. [The effect of vincristine on the morpho-functional state of the rat small intestine].
Brodskiĭ RA; Yavor T; Bandurko LN; Bero T; Iakovleva ND
Vopr Onkol; 1984; 30(8):95-101. PubMed ID: 6485290
[TBL] [Abstract][Full Text] [Related]
4. [Histoenzymatic changes in the white matter of the brain of young rats after the administration of vincristine in the second half of fetal life].
Godlewski A; Szczech J
Neuropatol Pol; 1984; 22(3):415-33. PubMed ID: 6514196
[No Abstract] [Full Text] [Related]
5. Histochemical changes in skeletal muscles of four male horses with neuromuscular disease.
Andrews FM; Spurgeon TL; Reed SM
Am J Vet Res; 1986 Sep; 47(9):2078-83. PubMed ID: 3767116
[TBL] [Abstract][Full Text] [Related]
6. Human muscle carbonic anhydrase III (CA-III). Purification, immunohistochemical localization in the human skeletal muscle and its clinical application to the neuromuscular disease.
Shima K
Hokkaido Igaku Zasshi; 1984 Mar; 59(2):98-116. PubMed ID: 6430772
[TBL] [Abstract][Full Text] [Related]
7. A new animal model of vincristine-induced nociceptive peripheral neuropathy.
Authier N; Gillet JP; Fialip J; Eschalier A; Coudore F
Neurotoxicology; 2003 Dec; 24(6):797-805. PubMed ID: 14637374
[TBL] [Abstract][Full Text] [Related]
8. Altered biological distribution and decreased neuromuscular toxicity of niosome encapsulated vincristine.
Parthasarathi G; Udupa N; Parameshwaraiah N; Pillai GK
Indian J Exp Biol; 1996 Feb; 34(2):124-30. PubMed ID: 8641713
[TBL] [Abstract][Full Text] [Related]
9. Preliminary observations on the effects of repetitive stimulation during neuromyopathies induced by vincristine.
Metral S; Tchernia G; Tran TL
Electroencephalogr Clin Neurophysiol; 1971 Apr; 30(4):368. PubMed ID: 4103552
[No Abstract] [Full Text] [Related]
10. [Histochemistry of skeletal muscle ATPase in neuromuscular diseases, with special reference to progressive muscular dystrophy].
Tomonaga M; Muro T
Igaku To Seibutsugaku; 1967 Jul; 75(1):32-6. PubMed ID: 4229920
[No Abstract] [Full Text] [Related]
11. Colchicine neuromyopathy in a renal transplant patient with normal muscle enzyme levels.
Cook M; Ramos E; Peterson J; Croker B
Clin Nephrol; 1994 Jul; 42(1):67-8. PubMed ID: 7923972
[No Abstract] [Full Text] [Related]
12. Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine-induced painful neuropathy in rat.
Tanner KD; Levine JD; Topp KS
J Comp Neurol; 1998 Jun; 395(4):481-92. PubMed ID: 9619501
[TBL] [Abstract][Full Text] [Related]
13. [Effects of repetitive stimulations during neuropathies due to vincristine. Preliminary observations].
Metral S; Tchernia G; Tran Long Trach TL
Rev Neurol (Paris); 1970 Oct; 123(4):275-9. PubMed ID: 4325810
[No Abstract] [Full Text] [Related]
14. [Experimental study on morphological changes of detrusor muscle and its neuromuscular junction after medullary cone injury in rats].
Hou C; Zheng X; Chen A
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 May; 21(5):473-7. PubMed ID: 17578285
[TBL] [Abstract][Full Text] [Related]
15. Species and sex differences in susceptibility to olfactory lesions among the mouse, rat and monkey following an intravenous injection of vincristine sulphate.
Kai K; Sahto H; Yoshida M; Suzuki T; Shikanai Y; Kajimura T; Furuhama K
Toxicol Pathol; 2006; 34(3):223-31. PubMed ID: 16698718
[TBL] [Abstract][Full Text] [Related]
16. Abnormal myomuscular junctions and AChE in a congenital neuromuscular disease.
Bormioli SP; Lücke S; Angelini C
Muscle Nerve; 1980; 3(3):240-7. PubMed ID: 7374674
[TBL] [Abstract][Full Text] [Related]
17. Spheromembranous degeneration of muscle induced by vincristine.
Slotwiner P; Song SK; Anderson PJ
Arch Neurol; 1966 Aug; 15(2):172-6. PubMed ID: 4287715
[No Abstract] [Full Text] [Related]
18. Neuromuscular function and organotin compounds.
Bierkamper GG; Aizenman E; Millington WR
Neurotoxicology; 1984; 5(2):245-65. PubMed ID: 6095143
[TBL] [Abstract][Full Text] [Related]
19. Reproductive toxicity of vincristine in male rats.
Stanley A; Averal HI; Akbarsha MA
Indian J Exp Biol; 1993 Apr; 31(4):380-2. PubMed ID: 8359837
[TBL] [Abstract][Full Text] [Related]
20. [Various features of muscle tissue metabolism in various muscular and neuromuscular diseases of a hereditary nature (clinico-histochemical study)].
Anosov NN; Saĭkova LA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(3):22-5. PubMed ID: 6952668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
